Suchergebnisse - "O3J8G9O825"

PubPharm (95)

11

Estimated glomerular filtration rates through 144 weeks on therapy in HIV-1-infected subjects receiving atazanavir/ritonavir and abacavir/lamivudine or simplified to unboosted atazanavir/abacavir/lamivudine

enthalten in: HIV clinical trials | 2015

von Young, B. | Squires, K. | Tashima, K. | +6

CommentOn: HIV Clin Trials. 2012 Sep-Oct;13(5):233-44. - PMID 23134624

12

Regimen selection in the OPTIONS trial of HIV salvage therapy : drug resistance, prior therapy, and race-ethnicity determine the degree of regimen complexity

enthalten in: HIV clinical trials | 2015

von Tashima, K. | Mollan, K. | Na, L. | +8

13

Week 144 resistance analysis of elvitegravir/cobicistat/emtricitabine/tenofovir DF versus atazanavir+ritonavir+emtricitabine/tenofovir DF in antiretroviral-naïve patients

enthalten in: HIV clinical trials | 2014

von Kulkarni, R. | Abram, M. | McColl, D. | +6

14

Efficacy and safety of darunavir/ritonavir plus etravirine dual regimen in antiretroviral therapy-experienced patients : a multicenter clinical experience

enthalten in: HIV clinical trials | 2014

von Gazzola, L. | Cicconi, P. | Ripamonti, D. | +6

15

Liver enzyme elevation during darunavir-based antiretroviral treatment in HIV-1-infected patients with or without hepatitis C coinfection : data from the ICONA foundation cohort

enthalten in: HIV clinical trials | 2014

von Di Biagio, A. | Nicolini, L. | Lorenzini, P. | +10

16

Is there a higher risk of CNS adverse events for PI monotherapy versus triple therapy? A review of results from randomized clinical trials

enthalten in: HIV clinical trials | 2014

von Powderly, W. | Hill, A. | Moecklinghoff, C.

17

Virologic and immunologic responses in treatment-naive patients to ritonavir-boosted atazanavir or efavirenz with a common backbone

enthalten in: HIV clinical trials | 2014

von Wang, Q. | Young, J. | Bernasconi, E. | +60

18

Efficacy and tolerability of darunavir/ritonavir in combination with abacavir/lamivudine : an option in selected HIV-infected patients

enthalten in: HIV clinical trials | 2013

von de los Santos, I. | Gómez-Berrocal, A. | Valencia, E. | +5

19

Randomized trial to evaluate cardiometabolic and endothelial function in patients with plasma HIV-1 RNA suppression switching to darunavir/ritonavir with or without nucleoside analogues

enthalten in: HIV clinical trials | 2013

von Guaraldi, G. | Zona, S. | Cossarizza, A. | +8

20

Lipid-lowering effect and efficacy after switching to etravirine in HIV-infected patients with intolerance to suppressive HAART

enthalten in: HIV clinical trials | 2013

von Casado, J. | de Los Santos, I. | Del Palacio, M. | +4